The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance
- 12 July 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 104 (2) , 183-192
- https://doi.org/10.1016/0304-3835(96)04250-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancersNature Medicine, 1995
- Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Genes & Development, 1994
- Two distinct deleted regions on the short arm of chromosome I in neuroblastomaGenes, Chromosomes and Cancer, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- Mammalian G1 cyclinsCell, 1993
- Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cellsCell, 1992
- Universal control mechanism regulating onset of M-phaseNature, 1990
- Deletions of Interferon Genes in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1990
- Chromosomal aberrations in human neuroblastomasCancer, 1977